Looks like a possible announcement during December along the lines of overcoming the final hurdle for EU approval.
From the announcement on 11/11:
“We are confident that this data will be sufficient for EU approval for sale (CE Mark). The final piece we need for CE Mark is the validation data from our new, larger scale manufacturing process and this will be available during December 2011.”
It would appear possible that approval itself could be shortly after that going by this announcement on 1/11:
"On Friday 28 October the EU Notified Body, British Standards Institute, completed an audit of the quality management systems of Tissue Therapies. This audit found no non-conformances and the Company will shortly receive the certificates of compliance necessary for the sale of VitroGro® wound healing products in the EU and Canada."
All previous announcements have reinforced commencement of sales in Q2 2012.
Let the good times roll!
Rev
what's next
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)